Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
1463.5000
23.10
(
1.60
%)
NSE
Jun 04, 2026
12:14 PM
44.03% Gain from 52W Low
Volume:
355.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
07 Nov 2025
1463.50
1.60%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1345 | Target met
Target
Axis Direct
We maintain our BUY recommendation on the stock with a TP of Rs 1,345/share.
Aurobindo Pharma has gained
20.91%
in the last 3 Months
More from Aurobindo Pharma Ltd.
Recommended
Market trades flat, Indian Energy Exchange's traded electricity volume grows 18.6% YoY in May
Trendlyne Marketwatch |
04 Jun 2026, 12:13PM
Is a dual threat coming for the Indian economy?
The Baseline |
04 Jun 2026, 12:11PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020